Actinium Pharmaceuticals, Inc. (ATNM)
1.34
+0.02
(+1.52%)
USD |
NYAM |
Jan 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Research and Development Expense (TTM): 20.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Altimmune, Inc. | 67.72M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Avanos Medical, Inc. | 22.70M |
| NovaBay Pharmaceuticals, Inc. | -- |